Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric Framework

Citation:

Ibrahim EIK, Friberg LE. CPT Pharmacometrics Syst Pharmacol. 2025 Dec;14(12):2186-2197. Epub 2025 Oct 11. PMID: 41074915.